Clinical Study of Obesity Associated Non-Alcoholic Fatty Liver Disease

范竹萍,邱德凯,谢渭芬,胡和平,陈岳祥,孙媛媛,刘苏,曾民德

DOI: https://doi.org/10.3969/j.issn.1008-1704.2004.03.004

2004-01-01

Abstract:Objective To study the pathogenesis of non alcoholic fatty liver disease(NAFLD) and the efficacy and safety of Orlistat plus low caroli diet in the treatment of NAFLD.Methods 107 patients were divided into 4 groups. Group A was obese associated NAFLD with abnormal liver test ( n =60),group B was obese without NAFLD( n =16), group C was obese associated NAFLD( n =12),group D was obese with both ALT and AST elevation ( n =19). Patients in group A was given Orlistat plus low caroli diet for 24 weeks. The laboratory parameters were tested for all patients.Results ①There were no significant differences in levels of insulin, leptin, free fatty acid(FFA), ferritin and the index of insulin resistance among 4 groups.The differences of the level of transforming growth factor β1(TGF β1)were significant between group A and C, and group C and D( P = 0.0003 ).②The levels of TGF β1 and FFA were negatively related with the ratio of liver/spleen in CT scan(LSR),AST and GGT were negatively related with LSR,and the white blood cells were positively related with LSR.③ Body mass index decrease to 10.76% ±4.52% in group A after 24 weeks therapy. The levels of AST、ALT、GGT and total bilirubin improved. The LSR also increased ( P 0.05 ).④The incidence of adverse events was 96.7% , almost manifested by oily stool.Conclusion Orlistat with low caroli diet can be used as a treatment option.